Prescribing Information: Gelclair for Help With Oral Mucositis Download Gelclair Patient Brochure: GELCLAIR® was approved by the FDA in 2001 and is specifically designed and approved for management and relief of pain in oral mucositis. It contains key ingredients that protect, hydrate and soothe the mouth and has a mild flavor.
 
If you are receiving chemotherapy or radiation to the head and/or neck, you are at risk for oral mucositis. People who smoke, drink alcohol, don’t practice daily oral care, wear ill-fitting braces or dentures, and/or have dry mouth while receiving chemotherapy or radiation are at greater risk for oral mucositis GELCLAIR® Bioadherent Oral Gel
 

Ingredients: Water, Maltodextrin, Propylene Glycol, Polyvinylpyrrolidone (PVP), Sodium Hyaluronate, Potassium Sorbate, Sodium Benzoate, Hydroxyethylcellulose, PEG-40 Hydrogenated Castor Oil, Disodium Edetate, Benzalkonium Chloride, Flavoring, Saccharin Sodium, Glycyrrhetinic Acid.

Pharmaceutical form: Concentrated oral gel

Contents: 15 mL per single-use packet. Commercial boxes contain 15 single-use packets. (NDC 24477-010-15)

Therapeutic group: Oral gel for the relief and management of pain

Indications: GELCLAIR® has a mechanical action indicated for the management of pain and relief of pain by adhering to the mucosal surface of the mouth, soothing oral lesions of various etiologies, including oral mucositis/stomatitis (may be caused by chemotherapy or radiation therapy), irritation due to oral surgery, traumatic ulcers caused by braces or ill-fitting dentures, or disease. Also indicated for diffuse aphthous ulcers.

Contraindications: The administration of GELCLAIR® is contraindicated in any patient with a known or suspected hypersensitivity to any of its ingredients.

Special precautions for use: Avoid eating or drinking for at least 1 hour after use. Do not use any packet that is not intact (torn, split, or otherwise damaged in any
way). If no improvement is noticed after 7 days, consult a physician.

Keep out of the reach of children.

Warning: Federal law restricts GELCLAIR® to sale by or on the order of a physician or properly licensed practitioner.

Interaction with other medicinal products and other forms of interaction: There are no known interactions with medicinal or other products.

Directions for use: Pour the entire contents of the single-use GELCLAIR® packet into a glass and add 1 tablespoon of water. If this dilution of GELCLAIR® is too thick, it may be diluted with an additional 1-2 tablespoons of water to achieve the desired thickness. Stir mixture well and use immediately. Rinse around the mouth for at least 1 minute or as long as possible to coat tongue, palate, throat, inside of cheeks, and all oral tissue thoroughly. Gargle and spit out. Use 3 times a day or as needed. Do not eat or drink for at least 1 hour following treatment. If water is not available, GELCLAIR® may be used undiluted. If GELCLAIR® is swallowed accidentally, no adverse effects are anticipated.

Side effects: At the time of producing this leaflet, no adverse effects have been reported in clinical trials with the use of GELCLAIR®. Postmarketing reports have included infrequent complaints of burning sensation in the mouth.

Overdose: At the time of producing this leaflet, no cases of overdose have been reported.

Storage: Store at room temperature, out of direct sunlight. The gel may become a little darker and thicker over time, but this does not affect its efficacy or safety. Do not use after the expiration date shown on the box and packet.

GELCLAIR® is a registered trademark of Helsinn Healthcare SA, Lugano, Switzerland.

Manufactured for: Helsinn Healthcare SA, Lugano, Switzerland
Marketed and distributed by:
EKR Therapeutics, Inc., Cedar Knolls, NJ 07927
Date of revision:
October 2006

Learn how to use Gelclair for help with Oral Mucositis.
   
 
   

 

HOME - Health Care Professionals - Contact Us - Understanding Oral Mucositis - Reducing Signs and Symptoms of Oral Mucositis - Managing Oral Mucositis - Clinical Experience Indications - Dosing and Administration

© 2007 EKR Therapeutics, Inc. All rights reserved.
Web Site Privacy Policy

Marketed and distributed by: EKR Therapeutics, Inc., Cedar Knolls, NJ 07927 under license of Helsinn Healthcare SA, Lugano, Switzerland
GELCLAIR® is a registered trademark of Helsinn Healthcare SA, Lugano, Switzerland.